Evidence map›Paper›PMID 36978405›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Antimicrobial Therapy Duration for Bloodstream Infections Caused by

Rodrigo Douglas Rodrigues, Rebeca Carvalho Lacerda Garcia, Gabriel Almeida Bittencourt, Vicente Bouchet Waichel, Ester Carvalho Lacerda Garcia, Maria Helena Rigatto

Registry-linked trialOpen access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440304 (Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440304 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections: Study Protocol

TypeinterventionalSponsorClinical Hospital Centre ZagrebRan2025 to 2027Enrolled108ConditionsInfections, Bacterial, Sepsis BacterialArmsFosfomycin, Eravacycline, ampicillin/sulbactam
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rodrigo Douglas RodriguesMedical Sciences Post Graduation Program, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.ORCID 0000-0003-1798-3085
Rebeca Carvalho Lacerda GarciaMedical Sciences Post Graduation Program, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.
Gabriel Almeida BittencourtMedical School, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre 90619-900, Brazil.
Vicente Bouchet WaichelMedical School, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre 90619-900, Brazil.
Ester Carvalho Lacerda GarciaMedical School, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, Brazil.
Maria Helena RigattoMedical Sciences Post Graduation Program, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.ORCID 0000-0001-9465-2613
Universidade Federal do Rio Grande do Sul · BRPontifícia Universidade Católica do Rio Grande do Sul · BRPontifícia Universidade Católica do Paraná · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES) finance code 001Research Incentive Fund of the Hospital de Clínicas de Porto Alegre. 2019-0740
6 · The paper itself

Abstract

backgroundIdeal therapy duration for

methodsWe performed a retrospective cohort study in two tertiary-care hospitals in Porto Alegre, Brazil, from 2013 to 2019. Eligible patients aged ≥18 years were included and excluded for the following criteria: polymicrobial infections, treatment with non-susceptible antibiotics, complicated infections, or early mortality (<8 days of active antimicrobial therapy). The 30-day mortality risk was evaluated using a Cox regression model.

resultsWe included 237 BSI episodes, 51.5% caused by

conclusionsLong-term therapies for non-complicated

Indexed as

Acinetobacter baumannii-calcoaceticus complexbloodstream infectionsPseudomonas aeruginosatreatment duration

Identifiers

PMID36978405
PMCPMC10044637
OpenAlexW4323565436

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read58
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.